Skip to main content
. 2022 Sep 13;10(9):e005145. doi: 10.1136/jitc-2022-005145

Table 4.

Response to C-CAR088 T cell therapy in response-evaluable population

Best overall response, n (%) Low-dose group Medium-dose group High-dose group Total
Response-evaluable population n=3 n=11 n=14 n=28
ORR 3 (100.0) 11 (100) 13 (92.9) 27 (96.4)
 sCR 0 (0.0) 5 (45.5) 8 (57.1) 13 (46.4)
 CR 0 (0.0) 1 (9.1) 2 (14.3) 3 (10.7)
 VGPR 3 (100.0) 4 (36.4) 2 (14.3) 9 (32.1)
 PR 0 (0.0) 1 (9.1) 1 (7.1) 2 (7.1)
SD 0 (0.0) 0 (0.0) 1 (7.1) 1 (3.6)

CR, complete response; ORR, overall response rate; PR, partial response; sCR, stringent complete response; SD, stable disease; VGPR, very good partial response.